# A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

> **NCT01335269** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 96 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BI 853520

## Key facts

- **NCT ID:** NCT01335269
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01335269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01335269, "A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01335269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*